| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |